{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T00:27:02Z","timestamp":1725409622153},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,3]]},"DOI":"10.7759\/cureus.68530","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T13:57:51Z","timestamp":1725371871000},"source":"Crossref","is-referenced-by-count":0,"title":["Virologic Failure, Clinical Characteristics, and Common Viral Mutations in HIV Patients From Southwestern Colombia: A Nested Case-Control Study"],"prefix":"10.7759","author":[{"given":"Mar\u00eda E","family":"Tello-Cajiao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonardo","family":"Montero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reynaldo","family":"Carvajal Ortiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"UNAIDS data 2022. (2023). Accessed. April 14, 2024: https:\/\/www.unaids.org\/en\/resources\/documents\/2023\/2022_unaids_data."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31311-4","article-title":"HIV","volume":"392","author":"Ghosn J","year":"2018","unstructured":"Ghosn J, Taiwo B, Seedat S, Autran B, Katlama C. HIV. Lancet. 2018, 392:685-97. 10.1016\/S0140-6736(18)31311-4","journal-title":"Lancet"},{"key":"ref3","unstructured":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. (2016). Accessed. January 22, 2024: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK374294\/."},{"key":"ref4","unstructured":"Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. (2023). Accessed. February 27, 2024: https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/whats-new."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-023-00452-3","article-title":"HIV infection","volume":"9","author":"Bekker LG","year":"2023","unstructured":"Bekker LG, Beyrer C, Mgodi N, et al.. HIV infection. Nat Rev Dis Primers. 2023, 9:42. 10.1038\/s41572-023-00452-3","journal-title":"Nat Rev Dis Primers"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/S12981-023-00572-6\/TABLES\/2","article-title":"Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review","volume":"20","author":"SeyedAlinaghi SA","year":"2023","unstructured":"SeyedAlinaghi SA, Afsahi AM, Moradi A, et al.. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review. AIDS Res Ther. 2023, 20:1-22. 10.1186\/S12981-023-00572-6\/TABLES\/2","journal-title":"AIDS Res Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2299-6","article-title":"Mechanisms of viral mutation","volume":"73","author":"Sanju\u00e1n R","year":"2016","unstructured":"Sanju\u00e1n R, Domingo-Calap P. Mechanisms of viral mutation. Cell Mol Life Sci. 2016, 73:4433-48. 10.1007\/s00018-016-2299-6","journal-title":"Cell Mol Life Sci"},{"key":"ref8","article-title":"","author":"Cuenta de Alto Costo (CAC)","year":"2023","unstructured":"Cuenta de Alto Costo (CAC), Fondo Colombiano de Enfermedades de Alto Costo. HIV Situation in Colombia 2022 (Article in Spanish). Bogot\u00e1, D.C., Colombia; 2023. https:\/\/cuentadealtocosto.org\/publicaciones\/situacion-del-vih-en-colombia-2022\/."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30172-7","article-title":"Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study","volume":"7","author":"Gupta-Wright A","year":"2020","unstructured":"Gupta-Wright A, Fielding K, van Oosterhout JJ, et al.. Virological failure, HIV-1 drug resistance, and early mortality in adults admitted to hospital in Malawi: an observational cohort study. Lancet HIV. 2020, 7:e620-8. 10.1016\/S2352-3018(20)30172-7","journal-title":"Lancet HIV"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0276730","article-title":"Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon","volume":"17","author":"Penda CI","year":"2022","unstructured":"Penda CI, Moukoko MM, Fokam J, et al.. Rate of virological failure and HIV-1 drug resistance among HIV-infected adolescents in routine follow-up on health facilities in Cameroon. PLoS One. 2022, 17:e0276730. 10.1371\/journal.pone.0276730","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(15)00536-8","article-title":"Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study","volume":"16","author":"Gregson J","year":"2016","unstructured":"Gregson J, Tang M, Ndembi N, et al.. Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. Lancet Infect Dis. 2016, 16:565-75. 10.1016\/S1473-3099(15)00536-8","journal-title":"Lancet Infect Dis"},{"key":"ref12","article-title":"Factors associated with virologic failure in HIV patients on antiretroviral therapy","volume":"5","author":"G\u00f3mez C","year":"2022","unstructured":"G\u00f3mez C, Madrigal-Cadavid J, Giraldo PA, Abad JM, Serna JA, Segura \u00c1, Estrada-Acevedo JI. Factors associated with virologic failure in HIV patients on antiretroviral therapy. Farmacia Hospitalaria. 2022, 5:282-9.","journal-title":"Farmacia Hospitalaria"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.25100\/cm.v45i4.1566","article-title":"Characterization of treatment failure in HIV positive patients in the Colombian Caribbean region","volume":"45","author":"De La Hoz JM","year":"2014","unstructured":"De La Hoz JM, Bola\u00f1o L, C\u00e1rdenas O, et al.. Characterization of treatment failure in HIV positive patients in the Colombian Caribbean region. Colomb Med. 2014, 45:162-7.","journal-title":"Colomb Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1086\/382488","article-title":"Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads","volume":"189","author":"Kieffer TL","year":"2004","unstructured":"Kieffer TL, Finucane MM, Nettles RE, et al.. Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads. J Infect Dis. 2004, 189:1452-65. 10.1086\/382488","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000544","article-title":"Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients","volume":"29","author":"Vandenhende MA","year":"2015","unstructured":"Vandenhende MA, Ingle S, May M, et al.. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. AIDS. 2015, 29:373-83. 10.1097\/QAD.0000000000000544","journal-title":"AIDS"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00183-6","article-title":"Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study","volume":"2","author":"Cesar C","year":"2015","unstructured":"Cesar C, Jenkins CA, Shepherd BE, et al.. Incidence of virological failure and major regimen change of initial combination antiretroviral therapy in the Latin America and the Caribbean: an observational cohort study. Lancet HIV. 2015, 2:e492-500. 10.1016\/S2352-3018(15)00183-6","journal-title":"Lancet HIV"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1177\/09564624231181156","article-title":"Reasons for antiretroviral switching in Colombia: a retrospective cohort study","volume":"34","author":"Valderrama-Beltr\u00e1n SL","year":"2023","unstructured":"Valderrama-Beltr\u00e1n SL, Mart\u00ednez-Vernaza S, Correa-Forero SV, et al.. Reasons for antiretroviral switching in Colombia: a retrospective cohort study. Int J STD AIDS. 2023, 34:921-31. 10.1177\/09564624231181156","journal-title":"Int J STD AIDS"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.farma.2010.01.013","article-title":"Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy (Article in Spanish)","volume":"34","author":"Mart\u00edn MT","year":"2010","unstructured":"Mart\u00edn MT, Rovira M, Massanes M, et al.. Analysis of the duration of and reasons for changing the first combination of antiretroviral therapy (Article in Spanish). Farm Hosp. 2010, 34:224-30. 10.1016\/j.farma.2010.01.013","journal-title":"Farm Hosp"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-8160-8","article-title":"HIV\/AIDS treatment failure and associated factors in Ethiopia: meta-analysis","volume":"20","author":"Endalamaw A","year":"2020","unstructured":"Endalamaw A, Mekonnen M, Geremew D, Yehualashet FA, Tesera H, Habtewold TD. HIV\/AIDS treatment failure and associated factors in Ethiopia: meta-analysis. BMC Public Health. 2020, 20:82. 10.1186\/s12889-020-8160-8","journal-title":"BMC Public Health"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.916454","article-title":"Determinants of virological failure among patients on first line highly active antiretroviral therapy (HAART) in Southwest Ethiopia: a case-control study","volume":"10","author":"Bogale B","year":"2022","unstructured":"Bogale B, Asefa A, Destaw A, et al.. Determinants of virological failure among patients on first line highly active antiretroviral therapy (HAART) in Southwest Ethiopia: a case-control study. Front Public Health. 2022, 10:916454. 10.3389\/fpubh.2022.916454","journal-title":"Front Public Health"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108939","article-title":"Risk factors for delayed entrance into care after diagnosis among patients with late-stage HIV disease in southern Vietnam","volume":"9","author":"Rangarajan S","year":"2014","unstructured":"Rangarajan S, Tram HN, Todd CS, et al.. Risk factors for delayed entrance into care after diagnosis among patients with late-stage HIV disease in southern Vietnam. PLoS One. 2014, 9:e108939. 10.1371\/journal.pone.0108939","journal-title":"PLoS One"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272405","article-title":"Achieving the 95 95 95 targets for all: a pathway to ending AIDS","volume":"17","author":"Frescura L","year":"2022","unstructured":"Frescura L, Godfrey-Faussett P, Feizzadeh AA, El-Sadr W, Syarif O, Ghys PD. Achieving the 95 95 95 targets for all: a pathway to ending AIDS. PLoS One. 2022, 17:e0272405. 10.1371\/journal.pone.0272405","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.846943","article-title":"Trends of transmitted and acquired drug resistance in Europe from 1981 to 2019: a comparison between the populations of late presenters and non-late presenters","volume":"13","author":"Miranda MN","year":"2022","unstructured":"Miranda MN, Pingarilho M, Pimentel V, et al.. Trends of transmitted and acquired drug resistance in Europe from 1981 to 2019: a comparison between the populations of late presenters and non-late presenters. Front Microbiol. 2022, 13:846943. 10.3389\/fmicb.2022.846943","journal-title":"Front Microbiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir967","article-title":"Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India","volume":"54","author":"Saravanan S","year":"2012","unstructured":"Saravanan S, Vidya M, Balakrishnan P, et al.. Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India. Clin Infect Dis. 2012, 54:995-1000. 10.1093\/cid\/cir967","journal-title":"Clin Infect Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2015.0138","article-title":"Gag-protease sequence evolution following protease inhibitor monotherapy treatment failure in HIV-1 viruses circulating in East Africa","volume":"31","author":"Sutherland KA","year":"2015","unstructured":"Sutherland KA, Goodall RL, McCormick A, et al.. Gag-protease sequence evolution following protease inhibitor monotherapy treatment failure in HIV-1 viruses circulating in East Africa. AIDS Res Hum Retroviruses. 2015, 31:1032-7. 10.1089\/aid.2015.0138","journal-title":"AIDS Res Hum Retroviruses"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/282868-virologic-failure-clinical-characteristics-and-common-viral-mutations-in-hiv-patients-from-southwestern-colombia-a-nested-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T13:58:00Z","timestamp":1725371880000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/282868-virologic-failure-clinical-characteristics-and-common-viral-mutations-in-hiv-patients-from-southwestern-colombia-a-nested-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.68530","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,3]]}}}